IndraLab

Statements


IKBKE inhibits CYLD. 3 / 5
1 | 2 1

sparser
"A similar mechanism is thought to occur in breast carcinogenesis where IKKε phosphorylates and inactivates CYLD ( xref )."

reach
"In addition, IKKepsilon has been reported to decrease the activity of CYLD, a deubiquitinating enzyme that negatively regulates IRF3/7 activation, thereby indirectly increasing IRF mediated signaling [XREF_BIBR, XREF_BIBR]."

reach
"IKKepsilon inhibits CYLD activity through phosphorylation, which results in the blockage of the deubiquination of TRAF2 and NF-kB essential modulator (NEMO), positive regulators of the classical NF-kB pathway."